Email this article Bladder neck stenosis surgery in interstitial cystitis / bladder pain syndrome treatment
- Authors: Medvedev V.L.1,2,3, Mihailov I.V.1,2, Lepetunov S.N.1,2,3, Medoev Y.N.2,3, Kogan M.I.3
-
Affiliations:
- Kuban State Medical University
- Regional Clinical Hospital No. 1 named after prof. S.V. Ochapovsky
- Rostov State Medical University
- Issue: Vol 10, No 1 (2020)
- Pages: 5-10
- Section: Original articles
- URL: https://journals.rcsi.science/uroved/article/view/18884
- DOI: https://doi.org/10.17816/uroved1015-10
- ID: 18884
Cite item
Abstract
Introduction. Current methods of interstitial cystitis / bladder pain syndrome (IC/BPS) treatment don’t allow to achieve long-term clinical remission.
Aim of the study was to investigate the clinical efficacy of bladder neck transurethral incision (TUI) in women with IC/BPS, who had bladder outlet obstruction signs.
Materials and methods. TUI was performed to patients with IC/BPS and proven bladder neck stenosis (n = 29). Assessment of the results of this operation was provided after 1, 3 and 6 months after surgical treatment. Treatment efficacy was evaluated by using Global Response Assessment (GRA) Scale, Pelvic Pain and Urgency / Frequency (PUF) Patient Symptom Scale, urination diaries, analysis of which allowed to determine functional bladder capacity, urinary frequency and nocturia. Pain assessment was made with 10-point Visual Analogue Pain Scale (VAS). Functional efficacy was evaluated with urodynamic examination, which included cystometric bladder capacity, maximal urinary flow rate and residual volume rate. Treatment results were compared with such in 39 patients with IC/BPS without signs of bladder neck stenosis.
Results. GRA score ≥2 had 96.5% and 72.4% in 1 and 3 months after bladder neck TUI, respectively. VAS, PUF Scale parameters, cystometric bladder capacity, maximal urinary flow rate, residual volume rate, urinary frequency and nocturia values also significantly improved after surgery.
Conclusions. This prospective clinical study is the first, in which IC/BPS course in women with bladder neck stenosis was investigated. It was noticed, that in 1 month after bladder TUI in 96.5% of patients decreased severity of IC/BPS symptoms, there were no urinary tract infection and local complications. In addition, this effect lasted for 3 months after surgery in 72.4% of patients and for 6 months in 68.9% of patients.
Full Text
##article.viewOnOriginalSite##About the authors
Vladimir L. Medvedev
Kuban State Medical University; Regional Clinical Hospital No. 1 named after prof. S.V. Ochapovsky; Rostov State Medical University
Email: medvedev_vl@mail.ru
ORCID iD: 0000-0001-8335-2578
Doctor of Medical Science, Professor, Chairman of the Department of Urology; Deputy Chief Physician for Urology, Head of the Urological Center of Scientific Research Institute; Professor of the Department of Urology and Human Reproductive Health (with a Course in Pediatric Urology-Andrology)
Russian Federation, Krasnodar; Krasnodar; Rostov-on-DonIgor V. Mihailov
Kuban State Medical University; Regional Clinical Hospital No. 1 named after prof. S.V. Ochapovsky
Email: miv67@yandex.ru
ORCID iD: 0000-0003-3724-2794
Doctor of Medical Sciences, Professor, Department of Urology; Doctor of the Oncourology Department
Russian Federation, KrasnodarSergey N. Lepetunov
Kuban State Medical University; Regional Clinical Hospital No. 1 named after prof. S.V. Ochapovsky; Rostov State Medical University
Author for correspondence.
Email: Lepetunov@gmail.com
ORCID iD: 0000-0001-6657-1496
Assistant of the Department of Urology; Urologist; Postgraduate, Department of Urology and Human Reproductive Health (with a Course in Pediatric Urology-Andrology)
Russian Federation, Krasnodar; Krasnodar; Rostov-on-DonYuriy N. Medoev
Regional Clinical Hospital No. 1 named after prof. S.V. Ochapovsky; Rostov State Medical University
Email: dadoev@list.ru
ORCID iD: 0000-0002-3726-0186
Urologist; Postgraduate, Department of Urology and Human Reproductive Health (with a Course in Pediatric Urology-Andrology)
Russian Federation, Krasnodar; Rostov-on-DonMikhail I. Kogan
Rostov State Medical University
Email: dept_kogan@mail.ru
ORCID iD: 0000-0002-1710-0169
Doctor of Medical Science, Professor, Chairman of the Department of Urology and Human Reproductive Health (with a Course in Pediatric Urology-Andrology)
Russian Federation, Rostov-on-DonReferences
- Hanno PM, Sant GR. Clinical highlights of the National institute of diabetes and digestive and kidney diseases / interstitial cystitis. Urology. 2001;57(6 Suppl 1):2-6. https://doi.org/10.1016/s0090-4295(01)01112-8.
- Gülpınar Ö, Esen B, Kayış A, et al. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2018;37(1):257-262. https://doi.org/10.1002/nau.23284.
- Nickel JC, Barkin J, Forrest J, et al. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology. 2005;65(4):654-658. https://doi.org/10.1016/j.urology.2004.10.071.
- Sant GR, Propert KJ, Hanno PM, et al. A pilot clinical trial of oral pentosan polysulphate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170(3):810-815. https://doi.org/10.1097/01.ju.0000083020.06212.3d.
- Hanno PM, Buehler J, Wein AJ. Use of amitriptyline in the treatment of interstitial cystitis. J Urol. 1989;141(4):846-848. https://doi.org/10.1016/s0022-5347(17)41029-9.
- Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol. 2005;171(6):2138-2141. https://doi.org/10.1097/01.ju.0000125139.91203.7a.
- Giannantoni A, Porena M, Costantini E, et al. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol. 2008;179(3):1031-1034. https://doi.org/10.1016/j.juro.2007.10.032.
- Медведев В.Л., Лепетунов С.Н. Ботулинический токсин в лечении интерстициального цистита // Вестник урологии. – 2017. – Т. 5. – № 3. – С. 68–78. [Medvedev VL, Lepetunov SN. Botulinum toxin A for the management of interstitial cystitis / bladder pain syndrome. Urology herald. 2017;5(3):68-78. (In Russ.)]. https://doi.org/10.21886/2306-6424-2017-5-3-68-78.
- Зайцев А.В., Шаров М.Н., Арефьева О.А., Пушкарь Д.Ю. Синдром болезненного мочевого пузыря / интерстициальный цистит: факторы прогноза клинического течения заболевания // Вестник урологии. – 2018. – Т. 6. – № 3. – С. 26–35. [Zaitsev AV, Sharov MN, Arefieva OA, Pushkar DYu. Interstitial cystitis/bladder pain syndrome: factors predicting the clinical course of the disease. Urology herald. 2018;6(3):26-35. (In Russ.)]. https://doi.org/10.21886/2308-6424-2018-6-3-26-35.
- Пушкарь Д.Ю., Касян Г.Р. Ошибки и осложнения в урогинекологии. – М.: ГЭОТАР-Медиа, 2017. – 377 с. [Pushkar’ DYu, Kasyan GR. Oshibki i oslozhneniya v uroginekologii. Moscow: GEOTAR-Media; 2017. 377 p. (In Russ.)].
- Глыбочко П.В., Коган М.И., Набока Ю.Л. Инфекции и воспаления в урологии. – М.: Медфорум, 2019. – 888 с. [Glybochko PV, Kogan MI, Naboka YuL. Infekcii i vospaleniya v urologii. Moscow: Medforum, 2019. 888 p. (In Russ.)].
- Петрос П. Женское тазовое дно. Функции, дисфункции и их лечение в соответствии с интегральной теорией / Пер. с англ. под ред. Д.Д. Шкарупы. 2-е изд. – М.: МЕДпресс-информ, 2016. – 396 с. [Petros P. The female pelvic floor. Function, dysfunction and management according to the Integral theory. Transl. from English ed. by D.D. Shkarupa. 2th ed. Moscow: MEDpress-inform; 2016. 396 p. (In Russ.)]
- Gillenwater JY, Wein AJ. Summary of the National institute of arthritis, diabetes, digestive and kidney diseases workshop on interstitial cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol. 1988;140(1):203-206. https://doi.org/10.1016/s0022-5347(17)41529-1.
- Lubeck DP, Whitmore K, Sant GR, et al. Psychometric validation of the O’Leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urology. 2001;57 (6 Suppl 1):62-66. https://doi.org/10.1016/s0090-4295(01)01126-8.
- Propert KJ, Mayer RD, Wang Y, et al. Responsiveness of symptom scales for interstitial cystitis. Urology. 2006;67(1):55-59. https://doi.org/10.1016/j.urology.2005.07.014.
